Improving prostate cancer care with advanced imaging techniques
Optimizing prostate cancer care: integrating risks, benefits, and patient experiences in the new era of molecular imaging
This study is looking at how new PET scans can help find prostate cancer earlier and improve treatment, while also checking for any possible downsides like side effects or stress, so that patients and doctors can make better choices together.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-10928716 on NIH RePORTER |
What this research studies
This research investigates the impact of new positron-emission tomography (PET) scans on prostate cancer diagnosis and treatment. It aims to understand how these imaging techniques can improve patient outcomes by detecting cancer earlier, while also considering potential negative effects such as increased treatment side effects and psychological stress. By analyzing data from various sources, the research will develop a decision model to help patients and healthcare providers weigh the benefits and risks of PET imaging in their treatment plans.
Who could benefit from this research
Good fit: Ideal candidates for this research include men diagnosed with prostate cancer who are considering or have undergone PET imaging as part of their treatment.
Not a fit: Patients who are not diagnosed with prostate cancer or those who are not candidates for PET imaging may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more informed decision-making for prostate cancer patients, ultimately improving their treatment outcomes and quality of life.
How similar studies have performed: Other research has shown promising results with advanced imaging techniques in cancer care, suggesting that this approach could lead to significant improvements in patient outcomes.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Leapman, Michael Stuart — Yale University
- Study coordinator: Leapman, Michael Stuart
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.